Blue Trust Inc’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-12
Closed -$412 – 2738
2025
Q3
$412 Hold
12
– – ﹤0.01% 2447
2025
Q2
$324 Hold
12
– – ﹤0.01% 2352
2025
Q1
$356 Hold
12
– – ﹤0.01% 2389
2024
Q4
$475 Sell
12
-2,769
-100% -$105K ﹤0.01% 2328
2024
Q3
$60.3K Buy
2,781
+1,395
+101% +$39.2K ﹤0.01% 1483
2024
Q2
$30.7K Buy
1,386
+1,329
+2,332% +$27.9K ﹤0.01% 1484
2024
Q1
$1.26K Sell
57
-522
-90% -$12.7K ﹤0.01% 1900
2023
Q4
$13K Buy
+579
New +$14K ﹤0.01% 1497
2023
Q1
– Sell
-76
Closed -$1K – 2655
2022
Q4
$1K Buy
+76
New +$1.77K ﹤0.01% 2150

Other funds holding VCYT

Blue Trust Inc's VCYT Position: Q4 2025 in Review

Blue Trust Inc sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 12 shares — an estimated $412 sold.

Blue Trust Inc first reported a position in VCYT in Q4 2022 and held it in 9 quarters. The position peaked at $60.3K in Q3 2024. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Blue Trust Inc reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • Blue Trust Inc sold 12 Veracyte shares in Q4 2025, an estimated $412.
  • Blue Trust Inc first reported a position in Veracyte in Q4 2022 and held it in 9 quarters.
  • Blue Trust Inc's Veracyte position peaked at $60.3K in Q3 2024.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Blue Trust Inc's 13F filing for Q4 2025, filed 16 Jan 2026.